CD79B and neoplasm: SELL (a regulator of lymphocyte homing) [27–29], RAMP2 (implicated in vascular remodeling) [30, 31], and CD79B (a B cell receptor component) [32, 33] exhibited tumor-specific upregulation and functional roles in GC proliferation, as validated by siRNA knockdown.